| Followers | 269 |
| Posts | 15407 |
| Boards Moderated | 1 |
| Alias Born | 03/28/2013 |
Tuesday, June 18, 2019 10:13:37 AM
Correct
Imo the insanely large and, often times, disappointing trials will increasingly become a thing of the past
I don’t expect this to be an overnight change
But I’d put good money on “precision medicine” “systems theory” “endocannabinoid medicine” “AI predictive medicine models” etc (perfect storm)
Oh wait, I already have
“Systems biology
Evolving hypothesis-free, exploratory, holistic (non-reductionistic), global, integrative, and interdisciplinary paradigm using advances in multimodal high-throughput
technological platforms that enable the examination of networks of biological path- ways where elevated amounts of structurally and functionally different molecules are simultaneously explored over time at a system level (i.e. at the level of cells, group of cells, tissues, organs, apparatuses, or even whole organisms)
Systems medicine
Holistic paradigm applying systems biology-based strategies to medical research. It aims at integrating a variety of considerable biomedical data at all levels of the cel- lular organization (by employing global, integrative, and statistical/mathematical/ computational modeling) to explicate the pathophysiological mechanisms, prognosis, diagnosis, and treatment of diseases
Systems theory
Translational research theory of the Precision Medicine paradigm. It is an interdisciplin- ary conceptual framework allowing for the conceptualization of novel/original mod-
els to extract and explicate all systems levels and different spatiotemporal data
types of complex polygenic diseases”
https://alzheimer-recherche.org/wp-content/uploads/2017/03/CLIMACTERIC_Precision-Medicine-Initiative-for-Alzheimer-s-disease_2017.pdf
Entirely new age of medicine is being born
Front row seat
Imo the insanely large and, often times, disappointing trials will increasingly become a thing of the past
I don’t expect this to be an overnight change
But I’d put good money on “precision medicine” “systems theory” “endocannabinoid medicine” “AI predictive medicine models” etc (perfect storm)
Oh wait, I already have
“Systems biology
Evolving hypothesis-free, exploratory, holistic (non-reductionistic), global, integrative, and interdisciplinary paradigm using advances in multimodal high-throughput
technological platforms that enable the examination of networks of biological path- ways where elevated amounts of structurally and functionally different molecules are simultaneously explored over time at a system level (i.e. at the level of cells, group of cells, tissues, organs, apparatuses, or even whole organisms)
Systems medicine
Holistic paradigm applying systems biology-based strategies to medical research. It aims at integrating a variety of considerable biomedical data at all levels of the cel- lular organization (by employing global, integrative, and statistical/mathematical/ computational modeling) to explicate the pathophysiological mechanisms, prognosis, diagnosis, and treatment of diseases
Systems theory
Translational research theory of the Precision Medicine paradigm. It is an interdisciplin- ary conceptual framework allowing for the conceptualization of novel/original mod-
els to extract and explicate all systems levels and different spatiotemporal data
types of complex polygenic diseases”
https://alzheimer-recherche.org/wp-content/uploads/2017/03/CLIMACTERIC_Precision-Medicine-Initiative-for-Alzheimer-s-disease_2017.pdf
Entirely new age of medicine is being born
Front row seat
Recent AVXL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 12:15:26 PM
- Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification • GlobeNewswire Inc. • 05/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:15:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:15:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/11/2026 08:30:22 PM
- CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus • IH Market News • 05/06/2026 02:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:04:59 AM
- Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
